Press Release FeedGet the RSS feed
Menu

GlobeNewswire

Disc Medicine Presents Initial Results from RESTORE-PV Phase 2 Trial in Patients with Polycythemia Vera (PV) at the 14th Society of Hematologic Oncology (SOHO) Annual Meeting

GlobeNewswire

WATERTOWN, Mass., Sept. 09, 2026 -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today presented positive initial results from the RESTORE-PV Phase 2 trial of DISC-3405 in patients with polycythemia vera (PV). The data, presented in a poster session at the 2026 Society of Hematologic Oncology (SOHO) annual meeting in Houston, TX, demonstrated that treatment with DISC-3405 increased hepcidin and lowered serum iron, translating to reduction in phlebotomy, controlled hematocrit, and improved symptom burden in patients with PV. These data will be featured in an oral presentation at the SOHO conference tomorrow, September 10. Disc also presented an encore of the positive results from the Phase 2 RALLY-MF trial of selcodebart (DISC-0974) in patients with anemia of myelofibrosis (MF) and a new systematic literature review characterizing the humanistic burden of anemia associated with MF through patient reported outcomes.

  1. Owl Labs Meeting Owl 5 UHD 4K 360˚ Camera Plug-and-Play Conferencing; More Info at B&HMeeting Owl 5 4K 360˚ Camera, you can host optimal-quality hybrid meetings without the complexity of an entire room system.
  2. GTCPrime מסכמת את השתתפותה ב-iFX Expo הונג קונג 2026, לאחר יומיים של תובנות ויצירת קשריםדובאי, איחוד האמירויות הערביות, Oct. 20, 2026 -- GTCPrime סיימה את השתתפותה כנותנת חסות בדרגת "זהב" בתערוכת iFX Expo Hong Kong 2026, שנערכה ב-8 וב-9 באוקטובר במרכז הכנסים והתערוכות של הונג קונג. במהלך יומיים אלו, אירח צוות GTCPrime לקוחות, שותפים ועמיתים מהתעשייה בדוכן מספר 14, במטרה לדון בהתפתחויות בשוק ובצרכים המשתנים של משקיעים ברחבי אזור אסיה-פסיפיק.
  3. Keith & Lorfing Partner Brandi Young Analyzes Maduro Torture Conspiracy Charges in FOX-Affiliate InterviewFormer federal prosecutor examines charging strategy, conspiracy law, immunity, and the potential impact of new allegations on federal court proceedings.
  4. HealthcareBronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor HarmNew class action for Hims & Hers (HIMS) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 11/1/2026
  5. FinanceGrupo Aeroportuario del Pacifico Announces Results for the Third Quarter of 2026Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) reports its consolidated results for the third quarter ended September 30, 2026 (3Q26). The results presented in this report include the effects of the business combination effective May 1, 2026. The figures are unaudited and have been prepared following International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”).
  6. Investissements PurposeInvestissements Purpose annonce les distributions d'octobre 2026TORONTO, 19 oct. 2026 -- Investissements Purpose (« Purpose ») a le plaisir d’annoncer des distributions pour le mois d'octobre 2026 pour ses fonds négociés en bourse à capital variable et ses fonds à capital fixe (les « Fonds »).